Bruce Daisley
Leading Voice on Workplace Culture & the Future of Work | Former VP of Twitter EMEA & Head of YouTube UK | #1 Sunday Times Bestselling Author | Host of Eat Sleep Work Repeat
James P. Allison
2018 Nobel Laureate in Physiology or Medicine | Founding Director, James P. Allison Institute at MD Anderson | Chair of Immunology | Pioneer of Cancer Immunotherapy
Few scientists can say their work created a new pillar of cancer care. James P. Allison, 2018 Nobel Laureate and Founding Director of the James P. Allison Institute at MD Anderson, showed that releasing the immune system's brakes lets the body destroy tumors. On stage he pairs rigorous science with a frank account of years defending an unpopular idea, a clear lesson for any leader in how breakthroughs happen.
Want to book James P. Allison as a speaker for your event? Please provide the info below and we’ll get in touch within 24h:
James P. Allison biography
Nobel Prize-winning immunologist and Nobel Prize speaker James P. Allison changed the way medicine fights cancer. Rather than attacking tumors directly, he asked what holds the immune system back, and found that releasing one of its natural brakes allows the body’s own T cells to destroy cancer. That insight founded immune checkpoint therapy, a class of treatment now used across many tumor types and credited with durable remissions for patients who once had few options.
Allison’s pivotal work centered on CTLA-4, a protein on T cells that dampens immune responses. In experiments in the mid-1990s, he showed that blocking CTLA-4 with an antibody led to striking tumor rejection in mice. Persuading industry to develop the idea took years of persistence, but it produced ipilimumab (Yervoy), the first immune checkpoint inhibitor approved by the U.S. FDA, for advanced melanoma.
A Career Built on Curiosity
Allison earned his Ph.D. at The University of Texas at Austin, trained at Scripps Clinic and Research Foundation, and began his independent career at MD Anderson’s Smithville research center. He later led research programs at UC Berkeley and Memorial Sloan Kettering Cancer Center before returning to The University of Texas MD Anderson Cancer Center, where he is Regental Professor and Chair of Immunology, Vice President of Immunobiology, and Founding Director of the James P. Allison Institute.
In 2018 he shared the Nobel Prize in Physiology or Medicine with Tasuku Honjo. His other honors include the Lasker-DeBakey Clinical Medical Research Award, the Breakthrough Prize in Life Sciences, the Balzan Prize, the King Faisal Prize in Medicine, and the AACR Award for Lifetime Achievement in Cancer Research, along with membership in the National Academy of Sciences and the National Academy of Medicine. His story is told in the PBS documentary Jim Allison: Breakthrough, and away from the lab he is an avid harmonica player.
As a speaker, James P. Allison combines the authority of a scientist who opened a new field with the candor of someone who spent years being told he was wrong. He speaks about the path from basic questions to clinical impact, the persistence it takes to champion an unpopular idea, and where cancer immunotherapy is headed next. Audiences in oncology, life sciences, pharma, research philanthropy, and corporate R&D leave with a clear view of how transformative science actually happens.
James P. Allison Speaking Videos
Nobel Lecture: James Allison, Nobel Prize in Physiology or Medicine 2018
Keynote Speech by Nobel Prize Winner Dr. James P. Allison
James P. Allison Keynote Topics
Allison walks audiences from a basic question about how T cells are switched off to the Nobel Prize-winning finding that blocking CTLA-4 lets the immune system reject tumors. He explains why the idea met resistance, how it became ipilimumab, and how checkpoint therapy grew into a standard pillar of oncology alongside surgery, radiation, and chemotherapy. The talk shows how a single, well-posed scientific question can reshape an entire field of medicine.
Why do some patients respond dramatically to immunotherapy while others see little benefit? Allison examines the science of response and resistance, the promise of combining checkpoint inhibitors with each other and with other treatments, and the open questions researchers must answer to extend these gains to more patients. Drawing on the work of the James P. Allison Institute at MD Anderson, he outlines how closer links between laboratory discovery and clinical trials are speeding progress.
For years, Allison presented checkpoint data to skeptical audiences and struggled to find a company willing to back it. In this candid keynote he describes what it took to keep going, how he read the evidence when others dismissed it, and the moment clinical results changed minds. The lessons carry well beyond science, speaking to any leadership team weighing a promising idea that challenges conventional wisdom.
Checkpoint immunotherapy did not come from a targeted drug program. It came from curiosity about how the immune system regulates itself. Allison makes a clear, evidence-based case for protecting long-term investment in basic science, and explains how institutions can structure research so that discovery and application strengthen each other. Especially relevant for research funders, academic medical centers, and corporate R&D leaders deciding how to balance applied and foundational work.
Speaker topics
FAQs on Booking James P. Allison
Why James P. Allison?
James P. Allison offers something rare: a first-hand account of how a Nobel Prize-winning idea went from a lab bench to a treatment that has changed outcomes for cancer patients worldwide. He pairs scientific authority with an honest story of persistence against doubt, which makes his talks as relevant to executives and innovators as to physicians and researchers. Audiences in oncology, biopharma, academic medicine, and research philanthropy come away with a sharper sense of what real breakthroughs demand. Contact Aurum Speakers Bureau to check his availability for your event.
What did James P. Allison win the Nobel Prize for?
James P. Allison shared the 2018 Nobel Prize in Physiology or Medicine with Tasuku Honjo for the discovery of cancer therapy by inhibition of negative immune regulation. Allison showed that CTLA-4, a protein on T cells, acts as a brake on immune responses, and that blocking it with an antibody allows the immune system to attack tumors. That work led to ipilimumab (Yervoy), the first approved immune checkpoint inhibitor, used to treat advanced melanoma.
What is immune checkpoint therapy?
Immune checkpoint therapy is a form of cancer immunotherapy that uses drugs to block proteins, such as CTLA-4 or PD-1, that normally keep immune responses in check. Tumors can exploit these checkpoints to avoid attack. By releasing them, checkpoint inhibitors allow T cells to recognize and destroy cancer cells. The approach is now used for many cancers, including melanoma and lung cancer, and in some patients produces long-lasting responses.
Why is James P. Allison a strong keynote choice for healthcare and innovation audiences?
Allison speaks with the credibility of a scientist who founded a field and the directness of someone who had to fight for it. His talks connect the science of immunotherapy to broader questions every organization faces: when to back an unproven idea, how to protect long-term research, and how to turn discovery into impact. That combination suits medical congresses, pharma leadership meetings, research foundation galas, and corporate innovation events. Aurum Speakers Bureau can help you shape the right format for your audience.
How to book James P. Allison as a keynote speaker?
Aurum Speakers Bureau can help you book James P. Allison as a speaker for your next event, conference, or board meeting. Simply fill out our contact form to inquire about James P. Allison's availability for a speaking engagement. One of our booking agents will respond to your request immediately and contact the speaker to let them know you want to hire them. We will assist you with obtaining speaking fees, booking information, and confirming availability for James P. Allison or any other top keynote speaker or celebrity of your choice.
How much is James P. Allison speaking fee?
James P. Allison speaking fees are determined by several factors, including the event's date, whether it's a virtual or in-person event, the duration, format, preparation required for their speech, and more. The same applies to the cost to hire any other top expert speakers and celebrities. The Speaker Fee Range listed on our website is simply a guideline and is subject to change without notice. If you would like to hire James P. Allison to deliver a keynote speech for your event, please fill out the contact form or email us at info@aurumbureau.com with as much detail as possible. One of our experienced agents will get in touch with you and let you know exactly how much it will cost to book James P. Allison.
How can I contact James P. Allison?
We only work with James P. Allison on paid speaking engagements. Aurum Speakers Bureau can assist you in booking James P. Allison and will handle all negotiations, contracts, and logistics associated with having James P. Allison speak at your event. We will be your sole point of contact throughout the process. Get in touch with Aurum Speakers Bureau today, and we will reach out to any motivational speaker or celebrity you want to enquire about speaking at your event. If you wish to contact James P. Allison for any other reason, we will be unable to assist you as we are not authorized to provide personal contact information.
Can I book James P. Allison for a virtual keynote?
Yes, James P. Allison is available for virtual keynotes and webinars. To book James P. Allison for a virtual event, please complete the contact form or send us an email to inquire about the special fees for virtual engagements.
